|
||||
>
2,000,000
members - join if you feel like itOnline
Used by people at: U.S. Army, U.S. Navy, U.S. Air Force, U.S. Marines, Boeing, Raytheon, Northrop-Grumman, IBM, Natrol, Oracle, Microsoft, NASA, Pfizer, Prudential, MetLife, AIG, States of CA, NY, Illinois, Virginia, City of New York, Stanford, Columbia, USC, NYU, UCSD, Harvard, MIT, and at hundreds of other organizations - why not join them? ![]() "I have used and reviewed the Cognitive Labs test services and find them quite helpful and timely for the growing market to detect early stages of cognitive dysfunction, e.g., mild cognitive impairment (MCI)" Yogesh Shah, M.D. Associate Program Director
Mercy/Mayo Family Practice Residency Program "I've found the Cognitive Labs test to be instrumental in determining which patients are at risk for dementia and in selecting those patients who may benefit from a cognitive enhancement program." David Leonardi, M.D. Medical Director Cenegenics Medical Institute "I have found the tests helpful in screening for early stage cognitive impairment, and in establishing a cognitive baseline so that I am better able to quantify outcomes..." Ron Rothenberg, M.D. Clinical Professor of Preventive and Family Medicine,
UCSD School of Medicine Director of Medical Education at Scripps Memorial Hospital in Encinitas, CA Founder, California Healthspan Institute "..I have seen significant positive results for those patients showing impairment and/or decline and have a baseline by which to measure their performance in the future. In addition to all these benefits, I have added a diagnostic tool and revenue source to my practice. The insurance approval rate is almost 100% and the approval rate amongst my patients is overwhelmingly positive." Ivan L. Goldsmith, M.D. West Tropicana Medical Centre "I have reviewed the software developed by Cognitive Labs and believe it is sufficiently developed to now serve an emerging new market for the early detection and diagnosis of cognitive-impairment...[and] may be an ideal instrument for both the selection of incipient brain disorders or disease, and the monitoring of subtle state changes to quantify disease progression, or improvement from therapy (Medication, etc.)." Arthur Jensen, Ph.D. Professor Emeritus, Educational Psychology University of California, Berkeley Member, Top 100 Psychologists of the 20th Century
![]() (c) 2007 Cognitive Labs | Feeds: RSS 2.0 Atom blog
| Affiliate
Program |
||||